Novavax faces plenty of uncertainty related to a deal it signed with a larger company. The biotech's pipeline doesn't look ...

The government-funded COVID-19 vaccination program is from Jan. 1 to Feb. 28 next year to be expanded to cover all residents ...

Novavax (NVAX) has been struggling to convince the market that its COVID era gains can translate into a durable vaccine business, and the stock’s recent slide reflects those doubts. See our latest ...

Novavax (NVAX) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some ...

We came across a bullish thesis on Novavax, Inc. on Ridire Research’s Substack. In this article, we will summarize the bulls’ ...

Novavax, Inc. (NASDAQ:NVAX) ranks among the most oversold biotech stocks to invest in. Novavax, Inc. (NASDAQ:NVAX) announced ...

Shares of two major Covid-19 vaccine makers declined Monday after a Food and Drug Administration official [claimed the shots]( ...

Novavax, Inc. recently announced at the Jefferies London Healthcare Conference 2025 that it is shifting its focus from direct COVID-19 commercial operations to an expanded research and development ...

US FDA's vaccine director Dr. Vinay Prasad wrote a memo to their staff that claimed multiple child deaths were related to ...

Why is antimony more important currently than ever before? Mr. Evans: Well, it’s not that it’s more important currently, it’s that it’s less available currently. There’s a shortage of antimony ...

Adjuvants help boost the immune response to the antigen in the vaccine, and can also help with dose sparing, according to a ...

FDA vaccines chief says internal review found 10 child deaths linked to Covid shots • Shift would remake flu immunization ...